1 completed, 1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Oroticaciduria 1: new trials by email Literature Review of Oroticaciduria 1 trials Research Report on Oroticaciduria 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders AMPD3, OMIM*102772, AMP Deaminase Deficiency, AK1, OMIM *103000, Adenylate Kinase Deficiency | Recruiting | National Human Genome Research Institute (NHGRI) | 999 | 2023-12-19 | 2026-08-19 | |
| Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria uridine triacetate - Hereditary Orotic Aciduria | Phase 3 | Completed | Wellstat Therapeutics | 4 | 2014-04-01 | 2017-07-31 |
ADA2 protein, human (1) · Adenine phosphoribosyltransferase deficiency (1) · Adenosine monophosphate deaminase deficiency (1) · Adenylosuccinate lyase deficiency (1) · Anemia (1) · Arts syndrome (1) · Beta-Ureidopropionase Deficiency (1) · Charcot-Marie-Tooth Disease (1) · Dihydropyrimidinase Deficiency (1) · Dihydropyrimidine Dehydrogenase Deficiency (1) · Genee-Wiedemann syndrome (1) · Hemolysis (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Inosine Triphosphatase Deficiency (1)
Blood Protein Disorders (1) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dysgammaglobulinemia (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hereditary Sensory and Motor Neuropathy (1)
National Human Genome Research Institute (NHGRI) (1) · Wellstat Therapeutics (1)
United States (2)